With just one fight in the UFC, Amanda Lemos has been suspended two years by USADA for a violation of the UFC anti-doping policy.
The suspension comes due to a November 8, 2017 failed test after her promotional debut loss to Leslie Smith at UFC Fight Night 113.
Via USADA release:
Lemos, 30, tested positive for stanozolol and its metabolite 16β-hydroxystanozolol following an out-of-competition urine test conducted on November 8, 2017. Stanozolol is a non-Specified Substance in the class of Anabolic Agents and prohibited at all times under the UFC Anti-Doping Policy, which has adopted the World Anti-Doping Agency Prohibited List.
Lemos’ two-year period of ineligibility, the standard sanction for a first offense involving a non-Specified Substance, began on November 8, 2017, the date her positive sample was collected
A loss for the 30-year-old as she will not be able to return to the UFC until the fall of next year. Stanozol is used as a performance enhancing drug and its unlikely that the women’s bantamweight had a viable excuse for why it showed up on her test.